Abstract

Traditional Chinese medicine (TCM) herbal formulae can be valuable therapeutic strategies and drug discovery resources. However, the active ingredients and action mechanisms of most TCM formulae remain unclear. Therefore, the identification of potent ingredients and their actions is a major challenge in TCM research. In this study, we used a network pharmacology approach we previously developed to help determine the potential antidiabetic ingredients from the traditional Ge-Gen-Qin-Lian decoction (GGQLD) formula. We predicted the target profiles of all available GGQLD ingredients to infer the active ingredients by clustering the target profile of ingredients with FDA-approved antidiabetic drugs. We also applied network target analysis to evaluate the links between herbal ingredients and pharmacological actions to help explain the action mechanisms of GGQLD. According to the predicted results, we confirmed that a novel antidiabetic ingredient from Puerariae Lobatae radix (Ge-Gen), 4-Hydroxymephenytoin, increased the insulin secretion in RIN-5F cells and improved insulin resistance in 3T3-L1 adipocytes. The network pharmacology strategy used here provided a powerful means for identifying bioactive ingredients and mechanisms of action for TCM herbal formulae, including Ge-Gen-Qin-Lian decoction.

Highlights

  • Type 2 diabetes (T2D), or noninsulin-dependent diabetes mellitus, is a common complex disease with an increasing prevalence worldwide

  • The successful application of Ge-Gen-Qin-Lian decoction (GGQLD) in T2D therapy demonstrated the feasibility of traditional Chinese medicine (TCM) herbal formulae and showed that increasing the complexity of proposed therapies by targeting different pathological processes in disease development should more efficiently treat complex diseases

  • A practical application of the network-based approach was illustrated in GGQLD and the results demonstrate that this approach is an effective strategy for TCM modern research

Read more

Summary

Introduction

Type 2 diabetes (T2D), or noninsulin-dependent diabetes mellitus, is a common complex disease with an increasing prevalence worldwide. Multiple genes are involved in genetic susceptibility, each making a small contribution to T2D risk [5, 6]. Treatments aimed at controlling high-level blood glucose, as well as therapies that prevent diabetic complications, have all shown specific therapeutic activity in T2D patients, such as metformin, alpha-glucosidase inhibitors, sulfonylureas, thiazolidinediones (TZDs), and insulin injections [10]. These treatments have shown limited efficacy and are associated with various side effects such as flatulence and diarrhea [11]. As a complicated disease, T2D may require complex therapeutic approaches such as traditional Chinese medicine (TCM) [12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call